10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001213900-21-025331`
Period End Date	20210331
Filing Date	20210510
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	aiki-20210331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 26 Cash Flow Statement 48 Stockholders Equity 20

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$252.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$24.80M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$92.43M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$215.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Short-term investment	`ShortTermInvestments`	$2.30M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	89.53M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$27.73M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	34.92M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$102.90M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	34.92M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	89.53M	shares	Point-in-time
Convertible note receivable	`NotesReceivableRelatedPartiesNoncurrent`	$2.03M	USD	Point-in-time
Investments	`Investments`	$2.76M	USD	Point-in-time
Total assets	`Assets`	$30.50M	USD	Point-in-time
Total assets	`Assets`	$104.93M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$244.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$567.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$310.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$315.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$559.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$877.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$559.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$877.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,531,149 and 34,920,222 shares issued at March 31, 2021 and December 31, 2020, respectively; 89,531,146 and 34,920,219 shares outstanding at March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 89,531,149 and 34,920,222 shares issued at March 31, 2021 and December 31, 2020, respectively; 89,531,146 and 34,920,219 shares outstanding at March 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$186.48M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$265.19M	USD	Point-in-time
Treasury stock, at cost, 3 shares at March 31, 2021 and December 31, 2020	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 3 shares at March 31, 2021 and December 31, 2020	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-160.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-156.60M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$104.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.53M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$29.62M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$20.98M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$104.93M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$30.50M	USD	Point-in-time

Income Statement 26 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.30M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.21M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$85.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$72.00K	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.01M	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.03M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.32M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.40M	USD	1 Quarter
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$135.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$27.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	-	USD	1 Quarter
Losses on marketable securities	`MarketableSecuritiesGainLoss`	$-863.00K	USD	1 Quarter
Losses on marketable securities	`MarketableSecuritiesGainLoss`	$-1.34M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-467.00K	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-5.07M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-5.93M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-1.64M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.96M	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.91	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	60.28M	shares	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.20M	shares	1 Quarter

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.96M	USD	1 Quarter
Change in fair value of investment	`ChangeInFairValueOfInvestments`	$467.00K	USD	1 Quarter
Change in fair value of investment	`ChangeInFairValueOfInvestments`	$5.07M	USD	1 Quarter
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.03M	USD	1 Quarter
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.01M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$112.00K	USD	1 Quarter
Realized (gain) loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$424.00K	USD	1 Quarter
Realized (gain) loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-44.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-2.05M	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-835.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-16.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-16.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$102.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-323.00K	USD	1 Quarter
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$-244.00K	USD	1 Quarter
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$5.00K	USD	1 Quarter
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$27.00K	USD	1 Quarter
Payable to DatChat	`IncreaseDecreaseInPayablesToDatchat`	$50.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.05M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.45M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$83.59M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$20.38M	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$14.34M	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$4.21M	USD	1 Quarter
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$503.00K	USD	1 Quarter
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$1.01M	USD	1 Quarter
Purchase of convertible note	`RepaymentOfConvertibleDebt`	$2.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.17M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-71.75M	USD	1 Quarter
Proceeds from issuance common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	$77.99M	USD	1 Quarter
Proceeds from issuance common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	$6.55M	USD	1 Quarter
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$5.09M	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.14M	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$84.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.78M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.07M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$161.00K	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$5.27M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.98M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$252.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.98M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$252.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.71M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Offering cost included in accrued expenses	`AccruedExpensesIncludedInOfferingCosts`	$7.00K	USD	1 Quarter

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Issuance of common stock, net of offering cost	`IssuanceOfCommonStockNetOfOfferingCost`	$8.26M	USD	1 Quarter
Issuance of common stock, net of offering cost	`IssuanceOfCommonStockNetOfOfferingCost`	$655.00K	USD	1 Quarter
Issuance of common stock and prefunded warrants net of offering cost	`IssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCost`	$958.00K	USD	1 Quarter
Balance	`StockholdersEquity`	$104.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time
Issuance of common stock, common warrants and prefunded warrants (net of offering costs of $958)	`StockIssuedDuringPeriodValueCommonStockCommonWarrantsAndPrefundedWarrantsnetOfOfferingCostsOf`	$6.54M	USD	1 Quarter
Issuance of common stock (net of offering costs of $655)	`StockIssuedDuringPeriodValueNewIssues`	$5.09M	USD	1 Quarter
Common warrant and prefunded warrant exercise	`StockIssuedDuringPeriodValueCommonWarrantAndPrefundedWarrantExercise`	$7.14M	USD	1 Quarter
Issuance of common stock and warrants (net of offering costs of $8,260)	`StockIssuedDuringPeriodValueOther`	$77.99M	USD	1 Quarter
Exercise of warrants	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$84.00K	USD	1 Quarter
Issuance of common stock for research and development license acquired	`StockIssuedDuringPeriodValueOfCommonStockForResearchAndDevelopmentLicenseAcquired`	$531.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$112.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.96M	USD	1 Quarter
Balance	`StockholdersEquity`	$104.37M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.